-
Cancer Cell: Aerobic exercise can reprogram the immune system and enhance anti-tumor immunity
Time of Update: 2022-11-04
Exercise promotes the survival of IL-15-sensitive CD8 T cells and doubles the number of home-based pancreatic ductal adenocarcinoma (PDAC) tumors in mice, resulting in effector T cells that have been shown by other studies to kill cancer cells.
-
IQVIA released the China PD-(L)1 market dynamics report for the first half of 2022
Time of Update: 2022-10-01
IQVIA Tumor Dynamic Information Database As of the time of the report, 15 PD-(L)1 products have been approved for marketing, and another 4 products are in the process of NDA new drug market applications, 3 of which are expected to be approved by the end of this year and early next year.
-
Treatment options for patients with high-risk advanced prostate cancer
Time of Update: 2021-11-14
Special report (1): The formation of the first-line NHT treatment of mCRPC, Professor Jing Yifeng from the First People's Hospital of Shanghai Jiaotong University mainly reported on three aspects: 1 The treatment of metastatic castration-resistant prostate cancer (mCRPC) The formation of the plan is very important; 2 Enzalutamide is a better first-line treatment of new hormone therapy (NHT); 3 In patients with poor prognostic factors, the benefit of enzalutamide treatment is clear .
-
Scientists reveal the pathogenesis of hepatomegaly and liver cancer caused by glycogen accumulation
Time of Update: 2021-11-01
This work found that early liver tumor cells use the extracted glucose to synthesize glycogen as energy storage, and inhibit the activity of the Hippo signaling pathway through liquid-liquid separation, thereby driving the occurrence and development of tumors .
-
Basic-level physicians and surgeons compete on the same stage, and the instructors of the digestive tract, hepatobiliary and pancreatic masters team up to call
Time of Update: 2021-10-11
General View of the Cases of Gastrointestinal Tumor by Primary Doctors▌ Case 1: Discussion on the combined treatment plan of radiotherapy and immune and anti-angiogenesis therapy for recurrence of esophageal cancer after surgery A case of “posterior abdominal lymph node metastasis” .
-
Will PD-1 / PD-L1 be approved in limited quantities? Breakthrough therapy is not approved for two main reasons
Time of Update: 2020-10-08
The 2020 CSCO Annual Conference was opened in Beijing on September 19, 2020. compared with previous years, CSCO venue using the largest conference hall, more than 2000 people will be surrounded by t
-
JAMA Surg: Cyan green lung targeted inhalation vs intravenous injection for lung cancer tumor edge identification
Time of Update: 2020-07-14
The recognition of tumor edges in surgery is very important for tumor removal, and intravenous indigoma (ICG) has some limitations in lung cancer excision Recently, researchers examined the clinical
-
1 rare case of lateral ventricular wall biliary lioma
Time of Update: 2020-06-25
The male, 21, was admitted to hospital on 31 May 2018 due to a physical impairment on his left side for 15 years At the age of 6, the patient found a right side ventricular wall occupatic lesions, a
-
Patient, male, 43, right upper limb activity is not good for more than January, accompanied by walkway instability for 7 days
Time of Update: 2020-05-29
Neurosurgery "Basic Information" patients, male, 43-year-old "Main Complaint" the right upper limb activity is not good in January, accompanied by walkway instability 7 days "current me
-
Qinyang mulou rabbit broker drives the development of rabbit industry
Time of Update: 2001-05-08
Introduction: [Qinyang mulou rabbit broker drives the development of rabbit industry] at 6 a.m., the Milky fog covers the quiet countryside "Let's go!" after the shouting, the motorcycles left the vil
